Davenport & CO LLC Bio Xcel Therapeutics, Inc. Transaction History

Davenport & CO LLC

$16.8 Billion
Q3 2024

A detailed history of Davenport & CO LLC transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Davenport & CO LLC holds 16,855 shares of BTAI stock, worth $10,787. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,855

Previous 21,205 20.51%

Holding current value

$10,787

Previous $27,000 62.96%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$0.53 - $1.34 $2,305 - $5,829	-4,350 Reduced 20.51%	16,855 $10,000
Q2 2024 Aug 06, 2024	SELL	$1.14 - $2.97 $15,025 - $39,144	-13,180 Reduced 38.33%	21,205 $27,000
Q1 2024 May 03, 2024	SELL	$1.95 - $4.04 $1,950 - $4,040	-1,000 Reduced 2.83%	34,385 $96,000
Q4 2023 Jan 23, 2024	SELL	$2.32 - $5.51 $60,598 - $143,921	-26,120 Reduced 42.47%	35,385 $104,000
Q3 2023 Oct 17, 2023	BUY	$2.49 - $11.85 $4,482 - $21,330	1,800 Added 3.01%	61,505 $155,000
Q2 2023 Jul 20, 2023	SELL	$6.39 - $28.58 $131,570 - $588,462	-20,590 Reduced 25.64%	59,705 $397,000
Q1 2023 Apr 27, 2023	SELL	$17.7 - $33.24 $1.36 Million - $2.55 Million	-76,810 Reduced 48.89%	80,295 $1.5 Million
Q4 2022 Jan 20, 2023	BUY	$10.25 - $22.43 $497,740 - $1.09 Million	48,560 Added 44.74%	157,105 $0
Q3 2022 Oct 11, 2022	BUY	$11.19 - $17.89 $255,971 - $409,233	22,875 Added 26.7%	108,545 $1.28 Million
Q2 2022 Jul 18, 2022	BUY	$9.03 - $21.55 $469,451 - $1.12 Million	51,988 Added 154.35%	85,670 $1.13 Million
Q1 2022 May 02, 2022	SELL	$15.0 - $22.83 $15,000 - $22,830	-1,000 Reduced 2.88%	33,682 $704,000
Q4 2021 Feb 10, 2022	BUY	$20.12 - $35.09 $243,693 - $425,010	12,112 Added 53.66%	34,682 $705,000
Q3 2021 Oct 14, 2021	BUY	$23.84 - $32.03 $206,096 - $276,899	8,645 Added 62.08%	22,570 $685,000
Q2 2021 Jul 28, 2021	SELL	$29.06 - $38.83 $297,138 - $397,036	-10,225 Reduced 42.34%	13,925 $405,000
Q1 2021 Apr 28, 2021	BUY	$39.04 - $64.6 $665,632 - $1.1 Million	17,050 Added 240.14%	24,150 $1.04 Million
Q4 2020 Jan 13, 2021	BUY	$42.46 - $56.58 $301,466 - $401,718	7,100 New	7,100 $328,000

Others Institutions Holding BTAI

# of Institutions

Shares Held

7.2M

Call Options Held

101K

Put Options Held

205K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $17.9M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account